Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fjoralba Zeka

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2015
RT-qPCR-based quantification of small non-coding RNAsFjoralba Zeka, Pieter Mestdagh, Jo Vandesompele
Scientific Reports|February 23, 2016
Straightforward and sensitive RT-qPCR based gene expression analysis of FFPE samplesFjoralba Zeka, Katrien Vanderheyden, Els De Smet, et al.
Journal of Microbiological Methods|March 30, 2011
Adherence and viability of intestinal bacteria to differentiated Caco-2 cells quantified by flow cytometryCharlotte Grootaert, Nico Boon, Fjoralba Zeka, et al.
Database : the Journal of Biological Databases and Curation|August 27, 2014
miRBase Tracker: keeping track of microRNA annotation changesGert Van Peer, Steve Lefever, Jasper Anckaert, et al.
NAR Cancer|January 23, 2023
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivationAlan Van Goethem, Jill Deleu, Nurten Yigit, et al.
Plos One|December 16, 2014
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patientsAli Rihani, Bram De Wilde, Fjoralba Zeka, et al.
Pediatric Blood & Cancer|January 7, 2014
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastomaAli Rihani, Tom Van Maerken, Bram De Wilde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2011
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samplesKatleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Nature Methods|November 1, 2013
The need for transparency and good practices in the qPCR literatureStephen A Bustin, Vladimir Benes, Jeremy Garson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 21, 2015
RT-qPCR-based quantification of small non-coding RNAsFjoralba Zeka, Pieter Mestdagh, Jo Vandesompele
Scientific Reports|February 23, 2016
Straightforward and sensitive RT-qPCR based gene expression analysis of FFPE samplesFjoralba Zeka, Katrien Vanderheyden, Els De Smet, et al.
Journal of Microbiological Methods|March 30, 2011
Adherence and viability of intestinal bacteria to differentiated Caco-2 cells quantified by flow cytometryCharlotte Grootaert, Nico Boon, Fjoralba Zeka, et al.
Database : the Journal of Biological Databases and Curation|August 27, 2014
miRBase Tracker: keeping track of microRNA annotation changesGert Van Peer, Steve Lefever, Jasper Anckaert, et al.
NAR Cancer|January 23, 2023
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivationAlan Van Goethem, Jill Deleu, Nurten Yigit, et al.
Plos One|December 16, 2014
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patientsAli Rihani, Bram De Wilde, Fjoralba Zeka, et al.
Pediatric Blood & Cancer|January 7, 2014
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastomaAli Rihani, Tom Van Maerken, Bram De Wilde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2011
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samplesKatleen De Preter, Pieter Mestdagh, Joëlle Vermeulen, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Nature Methods|November 1, 2013
The need for transparency and good practices in the qPCR literatureStephen A Bustin, Vladimir Benes, Jeremy Garson, et al.
Pageof 1